Create Medic Co., Ltd. (TYO:5187)
Japan · Delayed Price · Currency is JPY 1,144.00
-5.00 (-0.44%)
Sep 4, 2026, 3:30 PM JST
Create Medic Income Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 13,985 | 13,617 | 13,030 | 12,585 | 12,257 | 11,698 | |
Revenue Growth | 5.20% | 4.50% | 3.54% | 2.68% | 4.78% | 8.02% |
Cost of Revenue | 8,137 | 7,624 | 7,326 | 7,107 | 6,883 | 6,438 |
Gross Profit | 5,848 | 5,993 | 5,704 | 5,478 | 5,374 | 5,260 |
Selling, General & Admin | 5,055 | 4,988 | 5,011 | 4,675 | 4,636 | 4,393 |
Operating Expenses | 5,055 | 4,988 | 5,011 | 4,675 | 4,636 | 4,393 |
Operating Income | 793 | 1,005 | 693 | 803 | 738 | 867 |
Interest Expense | -2 | -7 | -10 | -10 | -7 | -6 |
Interest & Investment Income | 42 | 35 | 42 | 35 | 42 | 43 |
Currency Exchange Gain (Loss) | 12 | -55 | 3 | 26 | 26 | 84 |
Other Non Operating Income (Expenses) | 17 | 10 | 23 | 23 | 11 | 26 |
EBT Excluding Unusual Items | 862 | 988 | 751 | 877 | 810 | 1,014 |
Gain (Loss) on Sale of Investments | - | - | -29 | -24 | - | -75 |
Gain (Loss) on Sale of Assets | -2 | -30 | 297 | -5 | 4 | -5 |
Asset Writedown | -3 | -123 | -23 | - | - | - |
Other Unusual Items | 45 | 225 | 89 | 56 | 22 | 31 |
Pretax Income | 902 | 1,060 | 1,085 | 904 | 836 | 965 |
Income Tax Expense | 341 | 347 | 245 | 750 | 376 | 305 |
Net Income | 561 | 713 | 840 | 154 | 460 | 660 |
Net Income to Common | 561 | 713 | 840 | 154 | 460 | 660 |
Net Income Growth | -20.09% | -15.12% | 445.46% | -66.52% | -30.30% | 0.15% |
Shares Outstanding (Basic) | 8 | 8 | 9 | 9 | 9 | 9 |
Shares Outstanding (Diluted) | 9 | 9 | 9 | 9 | 9 | 9 |
Shares Change | 6.28% | 0.29% | -3.17% | 0.05% | 0.03% | -1.83% |
EPS (Basic) | 67.48 | 84.17 | 95.31 | 16.92 | 50.56 | 72.57 |
EPS (Diluted) | 61.48 | 80.75 | 95.31 | 16.92 | 50.56 | 72.57 |
EPS Growth | -24.71% | -15.27% | 463.32% | -66.54% | -30.33% | 2.02% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 507 | 115 | 1,865 | 263 | 201 | 949 |
Free Cash Flow Per Share | 55.49 | 13.01 | 211.60 | 28.89 | 22.09 | 104.34 |
Dividend Per Share | 28.000 | 45.000 | 37.000 | 37.000 | 37.000 | 37.000 |
Dividend Growth | -24.32% | 21.62% | 0% | 0% | 0% | 0% |
Gross Margin | 41.82% | 44.01% | 43.78% | 43.53% | 43.84% | 44.96% |
Operating Margin | 5.67% | 7.38% | 5.32% | 6.38% | 6.02% | 7.41% |
Profit Margin | 4.01% | 5.24% | 6.45% | 1.22% | 3.75% | 5.64% |
Free Cash Flow Margin | 3.62% | 0.84% | 14.31% | 2.09% | 1.64% | 8.11% |
EBITDA | 1,387 | 1,575 | 1,329 | 1,391 | 1,338 | 1,329 |
EBITDA Margin | 9.92% | 11.57% | 10.20% | 11.05% | 10.92% | 11.36% |
D&A For EBITDA | 594 | 570 | 636 | 588 | 600 | 462 |
EBIT | 793 | 1,005 | 693 | 803 | 738 | 867 |
EBIT Margin | 5.67% | 7.38% | 5.32% | 6.38% | 6.02% | 7.41% |
Effective Tax Rate | 37.80% | 32.74% | 22.58% | 82.97% | 44.98% | 31.61% |